Advertisement
Organisation › Details
Kyowa Kirin (Group)
Start | 2019-07-01 renamed | |
Predecessor | Kyowa Hakko Kirin (Group) | |
Industry | pharmaceutical | |
Person | Miyamoto, Masashi (Kyowa Kirin 201909 CEO) | |
Person 2 | Yamashita, Takeyoshi (Kyowa Kirin 202011 Executive Officer, Director Corporate Strategy + Planning) | |
Region | Tokyo | |
Country | Japan | |
Street | Otemachi Financial City Grand Cube, 1-9-2 Otemachi Chiyoda-ku | |
City | 100-0004 Tokyo | |
Tel | +81-3-5205-7200 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | G: 5,001 to 10,000 (2018-12-31) |
Currency | JPY | |
Annual sales | 346,531,000,000 (revenue, consolidated (2018) 2018-12-31) | |
Record changed: 2023-07-10 |
Advertisement
More documents for Kyowa Kirin (Group)
- [1] Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III"....
- [2] GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London....
- [3] GlaxoSmithKline plc. (8/21/19). "Press Release: GSK Submits First Regulatory Application for Daprodustat in Japan for Patients with Renal Anaemia Due to Chronic Kidney Disease". London....
- [4] GlaxoSmithKline plc. (11/22/18). "Press Release: GSK and Kyowa Hakko Kirin Sign Strategic Commercialisation Deal in Japan for Daprodustat, a Potential New Oral Treatment for Anaemia Associated with Chronic Kidney Disease". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top